A flurry of multi-billion dollar acquisitions by Pfizer, Genmab, and Axcelis signals renewed confidence and strategic positioning in high-growth sectors.
Key approvals and fast-track designations for Insmed, Alto Neuroscience, and Corcept Therapeutics boost investor confidence in the industry's regulatory landscape.
Analyst cites a 'stronger for longer' demand cycle for hard disk drives, fueled by the explosive growth of cloud computing and AI.
Analysts cite strong fundraising and execution as key drivers for the alternative asset manager's upgraded rating and bullish outlook.
The deal paves the way for the integration of Monogram's advanced surgical robotics, with a closing date set for early October 2025.
Irenic Capital reveals a 2% stake, urging the software firm to overhaul its board and explore strategic options after a period of underperformance.
Gaming giant to be acquired by a private equity consortium including Silver Lake and Saudi Arabia's PIF at a 25% premium, sending shares higher.
Singapore-based gaming and technology firm SACH Pte. Ltd. is set for a NASDAQ listing through the proposed combination.